NEW YORK, NY / ACCESSWIRE / September 18, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Insperity, Inc. (NYSE:NSP)
CONTACT JAKUBOWITZ ABOUT NSP:
https://claimyourloss.com/securities/insperity-inc-loss-submission-form/?id=9391&from=1
Class Period : February 11, 2019 - February 11, 2020
Lead Plaintiff Deadline : September 21, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had failed to negotiate appropriate rates with its customers for employee benefit plans and did not adequately disclose the risk of large medical claims from these plans; (b) Insperity was experiencing an adverse trend of large medical claims; (c) as a mitigating measure, the Company would be forced to increase the cost of its employee benefit plans, causing stunted customer growth and reduced customer retention; and (d) the foregoing issues were reasonably likely to, and would, materially impact Insperity’s financial results.
Vaxart, Inc. (NASDAQ:VXRT)
CONTACT JAKUBOWITZ ABOUT VXRT:
https://claimyourloss.com/securities/vaxart-inc-loss-submission-form/?id=9391&from=1
Class Period : June 25, 2020 - July 25, 2020
Lead Plaintiff Deadline : October 23, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.
Blink Charging Company (NASDAQ:BLNK)
CONTACT JAKUBOWITZ ABOUT BLNK:
https://claimyourloss.com/securities/blink-charging-company-loss-submission-form/?id=9391&from=1
Class Period : March 6, 2020 - August 19, 2020
Lead Plaintiff Deadline : October 23, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) many of Blink’s charging stations are damaged, neglected, non-functional, inaccessible, nor non-accessible; (ii) Blink’s purported partnerships and expansions with other companies were overstated; (iii) the purported growth of the Company’s network has been overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law